Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 9 | Rare Historical Photos

Health activists and patient groups seek revision of existing Biosimilar Guideline for increased access to critical drugs

These groups have written to the Central Health Ministry and Department of Biotechnology in this regard

The Hindu

Explained | The problem with India’s new guidelines on genetically modified insects

In April 2023, the Department of Biotechnology (DBT) issued the ‘Guidelines for Genetically Engineered (GE) Insects’. They provide procedural roadmaps for those interested in creating GE insects. They have three problems for researchers, discussed in the article.

The Hindu

3 Biotech Stocks With 'A' POWR Ratings

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the adoption of emerging technologies. Therefore, fundamentally strong biotech stocks Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) might be solid buys. These stocks are A (Strong Buy) rated in our proprietary…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks Every Investor Wants

Given inelastic demand, rapid breakthroughs, and government initiatives, the biotech industry looks well-positioned to thrive. So, quality biotech stocks Gilead Sciences (GILD), Biogen (BIIB), and Alkermes (ALKS) could be worth owning. Read on.

StockNews.com

2 Game-Changing Biotech Stocks, 1 to Sell Now

As the biotech industry looks well-positioned for solid growth driven by strong government support and a growing foothold of personalized medicines, it could be wise for investors to buy fundamentally strong biotech stocks Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN). However, fundamentally weak Titan Pharmaceuticals (TTNP) might be best avoided.…

StockNews.com

This will help empower people and improve economy of the State, says Priyank Kharge, after flagging off Shakti scheme

Rural Development and Panchayat Raj and Information and Biotechnology Minister Priyank Kharge has said that the Congress has kept its pre-poll promise by launching the Shakti scheme that allows women to travel free in government buses across the State. Addressing a gathering after flagging off the Shakti scheme at the…

The Hindu

Information on my educational qualifications is in my election affidavit, says Priyank Kharge

In response to questions from some BJP leaders on his educational qualifications, Rural Development and Panchayat Raj and Information and Biotechnology Minister Priyank Kharge has said that the information about his educational qualifications is in the affidavit that he submitted to the Election Commission of India along with his nomination…

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Holistic approach needed to tackle severe acute malnutrition: study

There is a need for a holistic approach to tackle the problem of severe acute malnutrition reveals a research study carried out by St. John’s Research Institute (SJRI) through funding received from Karnataka Biotechnology and Information Technology Services (KBITS).

The Hindu

Chart of the Day: Argenx - Great Biotech

The Chart of the Day belongs to the biotechnology company Argenx (ARGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

Barchart

India as a Quad-led biomanufacturing hub

India can become a leading player in the field of biomanufacturing and help the Quad, of India, Japan, Australia and the United States, to compete in this key area

The Hindu

2 Explosive Biotech Stocks to Own

The biotech industry is well-positioned to grow, thanks to breakthrough advances, rising chronic illness and government support. So, fundamentally solid biotech stocks, Genmab (GMAB) and Exelixis (EXEL) may be worth buying now. Read on.

StockNews.com

3 Biotech Stocks Primed for Growth

The biotechnology industry has been stoked by a blaze of advancements, breakthroughs, and investments, setting the stage for remarkable growth. With the industry catching a favorable wind, it could be wise to invest in robust biotech stocks MannKind Corporation (MNKD), POINT Biopharma (PNT), and LAVA Therapeutics (LVTX), which are primed…

StockNews.com

3 Buy Worthy Biotech Stocks for May

The biotech industry is well-positioned to witness significant growth with government support and breakthrough developments. Therefore, biotech stocks BioNTech SE (BNTX), Acorda Therapeutics (ACOR), and Shionogi (SGIOY) might be solid buys. Read on.

StockNews.com

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Stay Away From These 3 Stocks With Bearish Momentum in April

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

Asharq Al-Awsat

Seoul, Riyadh Seek Cooperation in Startups, Biotechnology

Saudi Arabia and South Korea are working to develop a comprehensive strategic cooperation, especially in the field of petrochemicals, energy supply chains, and the exchange of expertise and technological industries, with Seoul expressing interest in more vital partnerships that would also cover biotechnology industries and startups. Lee Young, South Korean…

Barchart

Chart of the Day: Aldeyra - Skyrocketing

The Chart of the Day belongs to the biotechnology company Aldeyra Therapeutics (ALDX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

StockNews.com

1 Biotech Stock to Buy in April 2023 and 1 to Sell

The biotech industry is predicted to grow steadily, driven by significant advancements, advancements in agriculture, biotechnology, and government initiatives. Also, during market downturns, the biotech sector tends to be more defensive than others. So, LAVA Therapeutics (LVTX) could be an ideal buy now. However, considering the lingering macroeconomic headwinds, fundamentally…

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Biotech Stocks Losing Momentum

As March comes to an end, biotech stocks Exelixis (EXEL), MacroGenics (MGNX), and Puma Biotechnology (PBYI) have been losing momentum. However, given the long-term prospects of the biotechnology industry and the administration’s push to boost domestic biomanufacturing, these biotech stocks could prove to be solid long-term investments. Read more.

StockNews.com

4 Biotech Stocks You Don’t Want to Miss out on in 2023

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading.

Radio France Internationale

China leads global competition for emerging technology, study shows

China has a "stunning lead" over the West in most critical and emerging technologies, a security thinktank has found after tracking defence, space, energy and biotechnology.

StockNews.com

3 Biotech Stocks to Buy in 2023 That Could Help Set You up for Life

The biotech industry is well-positioned to witness significant growth on the backs of soaring demands and government spending. Moreover, given the sector’s defensive nature, quality biotech stocks Amgen (AMGN), Gilead Sciences (GILD), and United Therapeutics Corp. (UTHR) might be solid buys in 2023 that could help you set for life.…

StockNews.com

5 Biotech Stocks That Could Make You Rich in 10 Years

The biotech industry is rapidly growing amid rising private and government investments and technological advancements. Given the solid prospects of the industry, fundamentally strong biotech stocks Amgen (AMGN), Vertex (VRTX), United Therapeutics (UTHR), Jazz Pharmaceuticals (JAZZ), and Exelixis (EXEL) might be ideal long-term investments for steady returns. Keep reading.

Tribune News Service

Blasting cancer into space: 2 Pa. students get ready to launch an experiment in microgravity

PITTSBURGH — Jason Gomes enrolled in Community College of Allegheny County to study biotechnology. Until this fall, he hadn't thought about sending cancer into space — or sending anything into space.

Asharq Al-Awsat

Saudi Investment Ministry Signs 2 MoUs at Riyadh Global Medical Biotechnology Summit

The Ministry of Investment signed two memorandums of understanding with Boehringer Ingelheim Company and Saudi Novo Nordisk Trading Company and King Abdullah University of Science and Technology at Riyadh Global Medical Biotechnology Summit 2023, the Saudi Press Agency reported Friday. The MoUs were signed in the presence of Minister of…

1 … 8 9 10 11

People

Narendra Modi

13,663 stories

Dipanjan BanchurSince

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

European Union

40,371 stories

Bharatiya Janata Party

the European Commission

The Election Commission of India

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.